130 related articles for article (PubMed ID: 29684152)
1. Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers.
Nielsen B; Kleppe A; Hveem TS; Pradhan M; Syvertsen RA; Nesheim JA; Kristensen GB; Trovik J; Kerr DJ; Albregtsen F; Danielsen HE
J Natl Cancer Inst; 2018 Dec; 110(12):1400-1408. PubMed ID: 29684152
[TBL] [Abstract][Full Text] [Related]
2. Chromatin organisation and cancer prognosis: a pan-cancer study.
Kleppe A; Albregtsen F; Vlatkovic L; Pradhan M; Nielsen B; Hveem TS; Askautrud HA; Kristensen GB; Nesbakken A; Trovik J; Wæhre H; Tomlinson I; Shepherd NA; Novelli M; Kerr DJ; Danielsen HE
Lancet Oncol; 2018 Mar; 19(3):356-369. PubMed ID: 29402700
[TBL] [Abstract][Full Text] [Related]
3. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
[TBL] [Abstract][Full Text] [Related]
4. Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas.
Nielsen B; Hveem TS; Kildal W; Abeler VM; Kristensen GB; Albregtsen F; Danielsen HE
Cytometry A; 2015 Apr; 87(4):315-25. PubMed ID: 25483227
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer.
Nielsen B; Albregtsen F; Kildal W; Abeler VM; Kristensen GB; Danielsen HE
Anal Cell Pathol (Amst); 2012; 35(4):305-14. PubMed ID: 22596183
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Bagnoli M; Canevari S; Califano D; Losito S; Maio MD; Raspagliesi F; Carcangiu ML; Toffoli G; Cecchin E; Sorio R; Canzonieri V; Russo D; Scognamiglio G; Chiappetta G; Baldassarre G; Lorusso D; Scambia G; Zannoni GF; Savarese A; Carosi M; Scollo P; Breda E; Murgia V; Perrone F; Pignata S; De Cecco L; Mezzanzanica D;
Lancet Oncol; 2016 Aug; 17(8):1137-1146. PubMed ID: 27402147
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of the Diversity of Nuclear Chromatin Compartments in Gynaecological Carcinomas.
Kleppe A; Albregtsen F; Trovik J; Kristensen GB; Danielsen HE
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33352679
[TBL] [Abstract][Full Text] [Related]
8. Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.
Wang L; Rambau PF; Kelemen LE; Anglesio MS; Leung S; Talhouk A; Köbel M
Histopathology; 2019 Feb; 74(3):452-462. PubMed ID: 30326146
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
Zuna RE; Behrens A
J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.
Binesh F; Akhavan A; Behniafard N; Zabihi S; Hosseinizadeh E
Asian Pac J Cancer Prev; 2014; 15(21):9405-10. PubMed ID: 25422232
[TBL] [Abstract][Full Text] [Related]
11. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
12. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer.
Ytre-Hauge S; Dybvik JA; Lundervold A; Salvesen ØO; Krakstad C; Fasmer KE; Werner HM; Ganeshan B; Høivik E; Bjørge L; Trovik J; Haldorsen IS
J Magn Reson Imaging; 2018 Dec; 48(6):1637-1647. PubMed ID: 30102441
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an immune gene-set based Prognostic signature in ovarian cancer.
Shen S; Wang G; Zhang R; Zhao Y; Yu H; Wei Y; Chen F
EBioMedicine; 2019 Feb; 40():318-326. PubMed ID: 30594555
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
15. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
Gultekin M; Kucukyildiz I; Karaca MZ; Dundar S; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
Int J Gynecol Cancer; 2017 Oct; 27(8S):S1-S9. PubMed ID: 30819761
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas.
Engqvist H; Parris TZ; Kovács A; Nemes S; Werner Rönnerman E; De Lara S; Biermann J; Sundfeldt K; Karlsson P; Helou K
BMC Cancer; 2019 Sep; 19(1):928. PubMed ID: 31533654
[TBL] [Abstract][Full Text] [Related]
19. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
[TBL] [Abstract][Full Text] [Related]
20. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
